Health Care

The healthcare industry is at a pivotal moment. The convergence of artificial intelligence (AI), creative dealmaking, and evolving market dynamics is driving substantial growth and transformation, creating new risks and opportunities for stakeholders. As a leading health care law firm, Ropes & Gray is uniquely positioned to help clients seize these opportunities and mitigate risks in this evolving environment, particularly in emerging areas like AI in health care.

A Recognized Leader in Health Care Law

• For over 50 years, Ropes & Gray has been a trusted partner to clients across the health care ecosystem—from providers and payors to pharmaceutical, life sciences, and digital health companies, and the investors that fuel their growth.
• Our team of more than 90 dedicated health care attorneys delivers practical, forward-looking legal solutions to navigate complex regulatory and business challenges.

Trusted Business Advisors at the Forefront of Innovation

• We offer forward-looking resources and first-to-market tools to accelerate diligence, streamline structuring, and provide market-leading insights, including:
  • HealthTrax: A real-time tracker for rapidly changing state and federal laws governing health care transactions.
  • Health AI Atlas: An interactive tracker of state regulations and federal de-regulatory efforts for AI in health care.
  • Proprietary Trend Analyses: Summaries of current trends and developments across the health care and life sciences industries. If you would like a copy, please reach out to [email protected].

Broad Experience, Deep Specialization

• Our experience covers the full spectrum of health care law matters: M&A, affiliations, joint ventures, and other transactions; regulatory counseling; reimbursement; fraud and abuse; health care data privacy and cybersecurity; and more.
• We also bring deep knowledge of areas such as: artificial intelligence (AI) in healthcare and life sciences, academic medicine, Administrative Procedure Act (APA) litigation, biomedical research (including research misconduct and foreign influence in research), digital health, drug pricing and price reporting, public finance, and value-based care.